Toopi Organics raises €11m from VisVires New Protein, european impact funds, BNP développement and existing investors

Altaïr Avocats supported lead investor VisVires New Protein in raising €11m for French start-up Toopi Organics alongside European impact funds, BNP Développement and existing investors.

Founded in 2019 by Michael Roes, Toopi Organics is a biotech start-up based in Gironde. Its main expertise lies in the collection and transformation of human urine into microbial biostimulant for use in agriculture.

This financing will enable the company to consolidate its presence in the agricultural market on a European scale and promote its industrial and commercial expansion in France and Belgium.

Altaïr Avocats was involved in the following aspects:
 

• Corporate & fundraising with a team composed of: Sébastien Péronne (partner), Céline Leparmentier-Delcourt.
• Contract & IP due diligence with a team comprising: Christophe Héry (partner), Albane Watine (associate).
• Tax due diligence with a team comprising: Damien Hautin (partner), Clémence Bauché (associate).

The participants in this operation :

• Toopi Organics was advised by Chammas & Marcheteau (Denis Marcheteau, Romain Penloup, Jeanne Cormerais).
• Investment bank: Avolta (Frédéric Ventre, Christina Fritz, Mehdy Laudrin)
• IP: Aquinov (Julie Cenatiempo)